{"transactions":[{"id":2030533,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":4,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-06T21:30:38.000Z","date":"2023-02-02","kind":"other","acquired":false,"shares":1500000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 2, 2023, Third Rock Ventures III, L.P. (\"TRV III\") distributed, for no consideration, 1,500,000 shares of Common Stock of the Issuer (the \"Shares\") to its limited partners and to Third Rock Ventures GP III, L.P. (\"TRV GP III\"), the general partner of TRV III, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP III distributed, for no consideration, the Shares it received in the distribution by TRV III to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 2, 2023, Third Rock Ventures III, L.P. (\"TRV III\") distributed, for no consideration, 1,500,000 shares of Common Stock of the Issuer (the \"Shares\") to its limited partners and to Third Rock Ventures GP III, L.P. (\"TRV GP III\"), the general partner of TRV III, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP III distributed, for no consideration, the Shares it received in the distribution by TRV III to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by TRV III. The general partner of TRV III is TRV GP III. The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual manager of TRV GP III LLC is Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":3185291,"source":{"system":"sec-edgar","filing":"0000899243-23-004046","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000089924323004046/doc4.xml","form_type":"4"}},{"id":2038515,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":4,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-02T00:26:33.000Z","date":"2023-02-01","kind":"sale","acquired":false,"shares":128642,"price":9.32,"value":1198943.44,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.25 to $9.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\"). The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual manager of TRV GP III LLC is Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":4685291,"source":{"system":"sec-edgar","filing":"0000899243-23-003161","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000089924323003161/doc4.xml","form_type":"4"}},{"id":2038514,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":4,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-02T00:26:33.000Z","date":"2023-01-31","kind":"sale","acquired":false,"shares":185000,"price":9.25,"value":1711250.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.15 to $9.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\"). The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual manager of TRV GP III LLC is Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":4813933,"source":{"system":"sec-edgar","filing":"0000899243-23-003161","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000089924323003161/doc4.xml","form_type":"4"}},{"id":2038513,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":4,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-02T00:26:33.000Z","date":"2023-01-30","kind":"sale","acquired":false,"shares":75000,"price":9.03,"value":677250.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.00 to $9.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\"). The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual manager of TRV GP III LLC is Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":4998933,"source":{"system":"sec-edgar","filing":"0000899243-23-003161","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000089924323003161/doc4.xml","form_type":"4"}},{"id":2040316,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":4,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-31T21:30:16.000Z","date":"2023-01-27","kind":"sale","acquired":false,"shares":50000,"price":9.02,"value":451000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.00 to $9.13, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\"). The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual manager of TRV GP III LLC is Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":5073933,"source":{"system":"sec-edgar","filing":"0000899243-23-003044","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000089924323003044/doc4.xml","form_type":"4"}},{"id":2044990,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":4,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-26T22:23:06.000Z","date":"2023-01-25","kind":"sale","acquired":false,"shares":50000,"price":9.22,"value":461000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.12 to $9.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\"). The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual manager of TRV GP III LLC is Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":5123933,"source":{"system":"sec-edgar","filing":"0000899243-23-002770","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000089924323002770/doc4.xml","form_type":"4"}},{"id":2044989,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":4,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-26T22:23:06.000Z","date":"2023-01-24","kind":"sale","acquired":false,"shares":100000,"price":9.27,"value":927000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.10 to $9.54, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\"). The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual manager of TRV GP III LLC is Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":5173933,"source":{"system":"sec-edgar","filing":"0000899243-23-002770","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000089924323002770/doc4.xml","form_type":"4"}},{"id":2047441,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":4,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-24T23:20:44.000Z","date":"2023-01-23","kind":"sale","acquired":false,"shares":55000,"price":9.06,"value":498300.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.00 to $9.15, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\"). The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual manager of TRV GP III LLC is Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":5273933,"source":{"system":"sec-edgar","filing":"0000899243-23-002483","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000089924323002483/doc4.xml","form_type":"4"}},{"id":2047440,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":4,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-24T23:20:44.000Z","date":"2023-01-20","kind":"sale","acquired":false,"shares":100000,"price":9.15,"value":915000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.00 to $9.49, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\"). The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual manager of TRV GP III LLC is Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":5328933,"source":{"system":"sec-edgar","filing":"0000899243-23-002483","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000089924323002483/doc4.xml","form_type":"4"}},{"id":2084907,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":4,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-12-15T16:30:20.000Z","date":"2022-12-13","kind":"other","acquired":false,"shares":2000000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 13, 2022, Third Rock Ventures III, L.P. (\"TRV III\") distributed for no consideration, 2,000,000 shares of Common Stock of the Issuer (the \"Shares\") to its limited partners and to Third Rock Ventures GP III, L.P. (\"TRV GP III\"), the general partner of TRV III, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP III distributed, for no consideration, the Shares it received in the distribution by TRV III to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 13, 2022, Third Rock Ventures III, L.P. (\"TRV III\") distributed for no consideration, 2,000,000 shares of Common Stock of the Issuer (the \"Shares\") to its limited partners and to Third Rock Ventures GP III, L.P. (\"TRV GP III\"), the general partner of TRV III, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP III distributed, for no consideration, the Shares it received in the distribution by TRV III to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by TRV III. The general partner of TRV III is TRV GP III. The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual manager of TRV GP III LLC is Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":1962202,"source":{"system":"sec-edgar","filing":"0000899243-22-038602","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1192595/000089924322038602/doc4.xml","form_type":"4"}},{"id":2099825,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":4,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-12-01T16:47:10.000Z","date":"2022-11-29","kind":"other","acquired":false,"shares":2000000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 29, 2022, Third Rock Ventures III, L.P. (\"TRV III\") distributed for no consideration, 2,000,000 shares of Common Stock of the Issuer (the \"Shares\") to its limited partners and to Third Rock Ventures GP III, L.P. (\"TRV GP III\"), the general partner of TRV III, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP III distributed, for no consideration, the Shares it received in the distribution by TRV III to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 29, 2022, Third Rock Ventures III, L.P. (\"TRV III\") distributed for no consideration, 2,000,000 shares of Common Stock of the Issuer (the \"Shares\") to its limited partners and to Third Rock Ventures GP III, L.P. (\"TRV GP III\"), the general partner of TRV III, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP III distributed, for no consideration, the Shares it received in the distribution by TRV III to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by TRV III. The general partner of TRV III is TRV GP III. The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual manager of TRV GP III LLC is Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":1839160,"source":{"system":"sec-edgar","filing":"0000899243-22-037288","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1192595/000089924322037288/doc4.xml","form_type":"4"}},{"id":2152605,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":4,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-22T16:59:43.000Z","date":"2022-09-20","kind":"other","acquired":false,"shares":2000000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a 10b5-1 trading plan adopted on August 5, 2022 by Third Rock Ventures III, L.P. (\"TRV III\"), TRV III distributed for no consideration, 2,000,000 shares of Common Stock of the Issuer (the \"Shares\") on September 20, 2022, to its limited partners and to Third Rock Ventures GP III, L.P. (\"TRV GP III\"), the general partner of TRV III, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP III distributed, for no consideration, the Shares it received in the distribution by TRV III to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to a 10b5-1 trading plan adopted on August 5, 2022 by Third Rock Ventures III, L.P. (\"TRV III\"), TRV III distributed for no consideration, 2,000,000 shares of Common Stock of the Issuer (the \"Shares\") on September 20, 2022, to its limited partners and to Third Rock Ventures GP III, L.P. (\"TRV GP III\"), the general partner of TRV III, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP III distributed, for no consideration, the Shares it received in the distribution by TRV III to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by TRV III. The general partner of TRV III is TRV GP III. The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual manager of TRV GP III LLC is Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":3839160,"source":{"system":"sec-edgar","filing":"0000899243-22-031705","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1192595/000089924322031705/doc4.xml","form_type":"4"}},{"id":2172863,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":4,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-26T20:15:31.000Z","date":"2022-08-25","kind":"sale","acquired":false,"shares":200000,"price":6.22,"value":1244000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.15 to $6.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\"). The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual manager of TRV GP III LLC is Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":5428933,"source":{"system":"sec-edgar","filing":"0000899243-22-029856","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000089924322029856/doc4.xml","form_type":"4"}},{"id":2172862,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":4,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-26T20:15:31.000Z","date":"2022-08-24","kind":"sale","acquired":false,"shares":149972,"price":6.09,"value":913329.48,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.05 to $6.21, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\"). The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual manager of TRV GP III LLC is Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":5628933,"source":{"system":"sec-edgar","filing":"0000899243-22-029856","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000089924322029856/doc4.xml","form_type":"4"}},{"id":2179526,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":4,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-18T20:15:11.000Z","date":"2022-08-16","kind":"sale","acquired":false,"shares":128456,"price":6.04,"value":775874.24,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\"). The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual manager of TRV GP III LLC is Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":5778905,"source":{"system":"sec-edgar","filing":"0000899243-22-029151","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000089924322029151/doc4.xml","form_type":"4"}},{"id":2184212,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":4,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-16T20:22:40.000Z","date":"2022-08-15","kind":"sale","acquired":false,"shares":135808,"price":6.04,"value":820280.32,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\"). The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual manager of TRV GP III LLC is Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":5907361,"source":{"system":"sec-edgar","filing":"0000899243-22-028793","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000089924322028793/doc4.xml","form_type":"4"}},{"id":2184211,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":4,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-16T20:22:40.000Z","date":"2022-08-12","kind":"sale","acquired":false,"shares":348007,"price":6.12,"value":2129802.84,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.376, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\"). The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual manager of TRV GP III LLC is Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":6043169,"source":{"system":"sec-edgar","filing":"0000899243-22-028793","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000089924322028793/doc4.xml","form_type":"4"}},{"id":2235658,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":4,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-06-10T19:07:15.000Z","date":"2022-06-08","kind":"sale","acquired":false,"shares":419901,"price":20.25,"value":8502995.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.25 to $20.41, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\"). The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual manager of TRV GP III LLC is Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares"}],"balance_after":5104130,"source":{"system":"sec-edgar","filing":"0000899243-22-022013","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1192595/000089924322022013/doc4.xml","form_type":"4"}},{"id":2511171,"issuer":{"id":15754,"kind":"organization","name":"Jounce Therapeutics, Inc.","symbol":"JNCE"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":6,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-16T19:57:50.000Z","date":"2021-11-12","kind":"sale","acquired":false,"shares":1900000,"price":8.38,"value":15922000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.30 to $8.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\"). The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":1148780,"source":{"system":"sec-edgar","filing":"0000899243-21-044916","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924321044916/doc4.xml","form_type":"4"}},{"id":2514654,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-12T17:26:03.000Z","date":"2021-11-10","kind":"other","acquired":false,"shares":1000000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a 10b5-1 trading plan adopted on September 8, 2021 by Third Rock Ventures III, L.P. (\"TRV III\"), TRV III distributed for no consideration, 1,000,000 shares of Common Stock of the Issuer (the \"Shares\") on November 10, 2021, to its limited partners and to Third Rock Ventures GP III, L.P. (\"TRV GP III\"), the general partner of TRV III, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP III distributed, for no consideration, the Shares it received in the distribution by TRV III to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to a 10b5-1 trading plan adopted on September 8, 2021 by Third Rock Ventures III, L.P. (\"TRV III\"), TRV III distributed for no consideration, 1,000,000 shares of Common Stock of the Issuer (the \"Shares\") on November 10, 2021, to its limited partners and to Third Rock Ventures GP III, L.P. (\"TRV GP III\"), the general partner of TRV III, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP III distributed, for no consideration, the Shares it received in the distribution by TRV III to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by TRV III. The general partner of TRV III is TRV GP III. The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":3962202,"source":{"system":"sec-edgar","filing":"0000899243-21-044424","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1192603/000089924321044424/doc4.xml","form_type":"4"}},{"id":2559716,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-09-24T16:13:34.000Z","date":"2021-09-22","kind":"other","acquired":false,"shares":1000000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a 10b5-1 trading plan adopted on March 30, 2021 by Third Rock Ventures III, L.P. (\"TRV III\"), TRV III distributed for no consideration, 1,000,000 shares of Common Stock of the Issuer (the \"Shares\") on September 22, 2021, to its limited partners and to Third Rock Ventures GP III, L.P. (\"TRV GP III\"), the general partner of TRV III, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP III distributed, for no consideration, the Shares it received in the distribution by TRV III to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to a 10b5-1 trading plan adopted on March 30, 2021 by Third Rock Ventures III, L.P. (\"TRV III\"), TRV III distributed for no consideration, 1,000,000 shares of Common Stock of the Issuer (the \"Shares\") on September 22, 2021, to its limited partners and to Third Rock Ventures GP III, L.P. (\"TRV GP III\"), the general partner of TRV III, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP III distributed, for no consideration, the Shares it received in the distribution by TRV III to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by TRV III. The general partner of TRV III is TRV GP III. The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":4962202,"source":{"system":"sec-edgar","filing":"0000899243-21-037614","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1192603/000089924321037614/doc4.xml","form_type":"4"}},{"id":2566333,"issuer":{"id":15754,"kind":"organization","name":"Jounce Therapeutics, Inc.","symbol":"JNCE"},"owners":[{"id":135402,"kind":"organization","name":"Third Rock Ventures II, L.P.","position":1,"cik":"0001488495","reported_name":"Third Rock Ventures II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135403,"kind":"organization","name":"Third Rock Ventures GP II, L.P.","position":2,"cik":"0001614061","reported_name":"Third Rock Ventures GP II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105511,"kind":"organization","name":"TRV GP II, LLC","position":3,"cik":"0001614073","reported_name":"TRV GP II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":6,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-09-17T16:15:22.000Z","date":"2021-09-15","kind":"other","acquired":false,"shares":1750000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a 10b5-1 trading plan adopted on November 18, 2020 by Third Rock Ventures II, L.P. (\"TRV II\"), TRV II distributed for no consideration, 1,750,000 shares of Common Stock of the Issuer (the \"Shares\") on September 15, 2021, to its limited partners and to Third Rock Ventures GP II, L.P. (\"TRV GP II\"), the general partner of TRV II, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP II distributed, for no consideration, the Shares it received in the distribution by TRV II to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to a 10b5-1 trading plan adopted on November 18, 2020 by Third Rock Ventures II, L.P. (\"TRV II\"), TRV II distributed for no consideration, 1,750,000 shares of Common Stock of the Issuer (the \"Shares\") on September 15, 2021, to its limited partners and to Third Rock Ventures GP II, L.P. (\"TRV GP II\"), the general partner of TRV II, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP II distributed, for no consideration, the Shares it received in the distribution by TRV II to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by TRV II. The general partner of TRV II is TRV GP II. The general partner of TRV GP II is TRV GP II, LLC (\"TRV GP II LLC\"). The individual managers of TRV GP II LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP II, TRV GP II LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":2697829,"source":{"system":"sec-edgar","filing":"0000899243-21-036411","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924321036411/doc4.xml","form_type":"4"}},{"id":2670486,"issuer":{"id":15754,"kind":"organization","name":"Jounce Therapeutics, Inc.","symbol":"JNCE"},"owners":[{"id":135402,"kind":"organization","name":"Third Rock Ventures II, L.P.","position":1,"cik":"0001488495","reported_name":"Third Rock Ventures II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135403,"kind":"organization","name":"Third Rock Ventures GP II, L.P.","position":2,"cik":"0001614061","reported_name":"Third Rock Ventures GP II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105511,"kind":"organization","name":"TRV GP II, LLC","position":3,"cik":"0001614073","reported_name":"TRV GP II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":6,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-14T16:19:56.000Z","date":"2021-06-10","kind":"other","acquired":false,"shares":1500000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a 10b5-1 trading plan adopted on November 18, 2020 by Third Rock Ventures II, L.P. (\"TRV II\"), TRV II distributed for no consideration, 1,500,000 shares of Common Stock of the Issuer (the \"Shares\") on June 10, 2021, to its limited partners and to Third Rock Ventures GP II, L.P. (\"TRV GP II\"), the general partner of TRV II, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP II distributed, for no consideration, the Shares it received in the distribution by TRV II to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to a 10b5-1 trading plan adopted on November 18, 2020 by Third Rock Ventures II, L.P. (\"TRV II\"), TRV II distributed for no consideration, 1,500,000 shares of Common Stock of the Issuer (the \"Shares\") on June 10, 2021, to its limited partners and to Third Rock Ventures GP II, L.P. (\"TRV GP II\"), the general partner of TRV II, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP II distributed, for no consideration, the Shares it received in the distribution by TRV II to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by TRV II. The general partner of TRV II is TRV GP II. The general partner of TRV GP II is TRV GP II, LLC (\"TRV GP II LLC\"). The individual managers of TRV GP II LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP II, TRV GP II LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":4447829,"source":{"system":"sec-edgar","filing":"0000899243-21-023555","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924321023555/doc4.xml","form_type":"4"}},{"id":2679577,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":135402,"kind":"organization","name":"Third Rock Ventures II, L.P.","position":1,"cik":"0001488495","reported_name":"Third Rock Ventures II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135403,"kind":"organization","name":"Third Rock Ventures GP II, L.P.","position":2,"cik":"0001614061","reported_name":"Third Rock Ventures GP II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105511,"kind":"organization","name":"TRV GP II, LLC","position":3,"cik":"0001614073","reported_name":"TRV GP II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":6,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-07T18:10:38.000Z","date":"2021-06-04","kind":"sale","acquired":false,"shares":164996,"price":30.23,"value":4987829.08,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.10 to $30.76, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures II, L.P. (\"TRV II\"). The general partner of TRV II is Third Rock Ventures GP II, L.P. (\"TRV GP II\"). The general partner of TRV GP II is TRV GP II, LLC (\"TRV GP II LLC\"). The individual managers of TRV GP II LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP II, TRV GP II LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-022345","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924321022345/doc4.xml","form_type":"4"}},{"id":2679576,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":135402,"kind":"organization","name":"Third Rock Ventures II, L.P.","position":1,"cik":"0001488495","reported_name":"Third Rock Ventures II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135403,"kind":"organization","name":"Third Rock Ventures GP II, L.P.","position":2,"cik":"0001614061","reported_name":"Third Rock Ventures GP II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105511,"kind":"organization","name":"TRV GP II, LLC","position":3,"cik":"0001614073","reported_name":"TRV GP II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":6,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-07T18:10:38.000Z","date":"2021-06-03","kind":"sale","acquired":false,"shares":378117,"price":30.2,"value":11419133.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures II, L.P. (\"TRV II\"). The general partner of TRV II is Third Rock Ventures GP II, L.P. (\"TRV GP II\"). The general partner of TRV GP II is TRV GP II, LLC (\"TRV GP II LLC\"). The individual managers of TRV GP II LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP II, TRV GP II LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":164996,"source":{"system":"sec-edgar","filing":"0000899243-21-022345","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924321022345/doc4.xml","form_type":"4"}},{"id":2693747,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":135402,"kind":"organization","name":"Third Rock Ventures II, L.P.","position":1,"cik":"0001488495","reported_name":"Third Rock Ventures II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135403,"kind":"organization","name":"Third Rock Ventures GP II, L.P.","position":2,"cik":"0001614061","reported_name":"Third Rock Ventures GP II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105511,"kind":"organization","name":"TRV GP II, LLC","position":3,"cik":"0001614073","reported_name":"TRV GP II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":6,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-05-27T17:43:46.000Z","date":"2021-05-26","kind":"sale","acquired":false,"shares":1231204,"price":30.53,"value":37588658.12,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.50 to $31.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures II, L.P. (\"TRV II\"). The general partner of TRV II is Third Rock Ventures GP II, L.P. (\"TRV GP II\"). The general partner of TRV GP II is TRV GP II, LLC (\"TRV GP II LLC\"). The individual managers of TRV GP II LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP II, TRV GP II LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares"}],"balance_after":543113,"source":{"system":"sec-edgar","filing":"0000899243-21-020885","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924321020885/doc4.xml","form_type":"4"}},{"id":2693746,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":135402,"kind":"organization","name":"Third Rock Ventures II, L.P.","position":1,"cik":"0001488495","reported_name":"Third Rock Ventures II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135403,"kind":"organization","name":"Third Rock Ventures GP II, L.P.","position":2,"cik":"0001614061","reported_name":"Third Rock Ventures GP II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105511,"kind":"organization","name":"TRV GP II, LLC","position":3,"cik":"0001614073","reported_name":"TRV GP II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":6,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-05-27T17:43:46.000Z","date":"2021-05-25","kind":"sale","acquired":false,"shares":135000,"price":30.93,"value":4175550.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.85 to $31.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures II, L.P. (\"TRV II\"). The general partner of TRV II is Third Rock Ventures GP II, L.P. (\"TRV GP II\"). The general partner of TRV GP II is TRV GP II, LLC (\"TRV GP II LLC\"). The individual managers of TRV GP II LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP II, TRV GP II LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares"}],"balance_after":1774317,"source":{"system":"sec-edgar","filing":"0000899243-21-020885","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924321020885/doc4.xml","form_type":"4"}},{"id":2693745,"issuer":{"id":15754,"kind":"organization","name":"Jounce Therapeutics, Inc.","symbol":"JNCE"},"owners":[{"id":135402,"kind":"organization","name":"Third Rock Ventures II, L.P.","position":1,"cik":"0001488495","reported_name":"Third Rock Ventures II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135403,"kind":"organization","name":"Third Rock Ventures GP II, L.P.","position":2,"cik":"0001614061","reported_name":"Third Rock Ventures GP II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105511,"kind":"organization","name":"TRV GP II, LLC","position":3,"cik":"0001614073","reported_name":"TRV GP II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":6,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-05-27T17:42:04.000Z","date":"2021-05-25","kind":"sale","acquired":false,"shares":552520,"price":8,"value":4420160.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.00 to $8.06, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by Third Rock Ventures II, L.P. (\"TRV II\"). The general partner of TRV II is Third Rock Ventures GP II, L.P. (\"TRV GP II\"). The general partner of TRV GP II is TRV GP II, LLC (\"TRV GP II LLC\"). The individual managers of TRV GP II LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP II, TRV GP II LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":5947829,"source":{"system":"sec-edgar","filing":"0000899243-21-020883","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924321020883/doc4.xml","form_type":"4"}},{"id":2721226,"issuer":{"id":1156,"kind":"organization","name":"Nurix Therapeutics, Inc.","symbol":"NRIX"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":6,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-05-10T16:41:16.000Z","date":"2021-05-06","kind":"other","acquired":false,"shares":1085784,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a 10b5-1 trading plan adopted on October 29, 2020 by Third Rock Ventures III, L.P. (\"TRV III\"), TRV III distributed for no consideration, 1,085,784 shares of Common Stock of the Issuer (the \"Shares\") on May 6, 2021 to its limited partners and to Third Rock Ventures GP III, L.P. (\"TRV GP III\"), the general partner of TRV III, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP III distributed, for no consideration, the Shares it received in the distribution by TRV III to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to a 10b5-1 trading plan adopted on October 29, 2020 by Third Rock Ventures III, L.P. (\"TRV III\"), TRV III distributed for no consideration, 1,085,784 shares of Common Stock of the Issuer (the \"Shares\") on May 6, 2021 to its limited partners and to Third Rock Ventures GP III, L.P. (\"TRV GP III\"), the general partner of TRV III, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP III distributed, for no consideration, the Shares it received in the distribution by TRV III to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by TRV III. The general partner of TRV III is TRV GP III. The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":3422549,"source":{"system":"sec-edgar","filing":"0000899243-21-018932","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924321018932/doc4.xml","form_type":"4"}},{"id":2789455,"issuer":{"id":15754,"kind":"organization","name":"Jounce Therapeutics, Inc.","symbol":"JNCE"},"owners":[{"id":135402,"kind":"organization","name":"Third Rock Ventures II, L.P.","position":1,"cik":"0001488495","reported_name":"Third Rock Ventures II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135403,"kind":"organization","name":"Third Rock Ventures GP II, L.P.","position":2,"cik":"0001614061","reported_name":"Third Rock Ventures GP II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105511,"kind":"organization","name":"TRV GP II, LLC","position":3,"cik":"0001614073","reported_name":"TRV GP II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":6,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-15T16:15:26.000Z","date":"2021-03-11","kind":"other","acquired":false,"shares":1250000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a 10b5-1 trading plan adopted on November 18, 2020 by Third Rock Ventures II, L.P. (\"TRV II\"), TRV II distributed for no consideration, 1,250,000 shares of Common Stock of the Issuer (the \"Shares\") on March 11, 2021, to its limited partners and to Third Rock Ventures GP II, L.P. (\"TRV GP II\"), the general partner of TRV II, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP II distributed, for no consideration, the Shares it received in the distribution by TRV II to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to a 10b5-1 trading plan adopted on November 18, 2020 by Third Rock Ventures II, L.P. (\"TRV II\"), TRV II distributed for no consideration, 1,250,000 shares of Common Stock of the Issuer (the \"Shares\") on March 11, 2021, to its limited partners and to Third Rock Ventures GP II, L.P. (\"TRV GP II\"), the general partner of TRV II, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP II distributed, for no consideration, the Shares it received in the distribution by TRV II to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by TRV II. The general partner of TRV II is TRV GP II. The general partner of TRV GP II is TRV GP II, LLC (\"TRV GP II LLC\"). The individual managers of TRV GP II LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP II, TRV GP II LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":6500349,"source":{"system":"sec-edgar","filing":"0000899243-21-011577","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924321011577/doc4.xml","form_type":"4"}},{"id":2814600,"issuer":{"id":15754,"kind":"organization","name":"Jounce Therapeutics, Inc.","symbol":"JNCE"},"owners":[{"id":135402,"kind":"organization","name":"Third Rock Ventures II, L.P.","position":1,"cik":"0001488495","reported_name":"Third Rock Ventures II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135403,"kind":"organization","name":"Third Rock Ventures GP II, L.P.","position":2,"cik":"0001614061","reported_name":"Third Rock Ventures GP II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105511,"kind":"organization","name":"TRV GP II, LLC","position":3,"cik":"0001614073","reported_name":"TRV GP II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":6,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-03T18:00:55.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":1450000,"price":11.75,"value":17037500.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares are directly held by Third Rock Ventures II, L.P. (\"TRV II\"). The general partner of TRV II is Third Rock Ventures GP II, L.P. (\"TRV GP II\"). The general partner of TRV GP II is TRV GP II, LLC (\"TRV GP II LLC\"). The individual managers of TRV GP II LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP II, TRV GP II LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":7750349,"source":{"system":"sec-edgar","filing":"0000899243-21-009481","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924321009481/doc4.xml","form_type":"4"}},{"id":2830052,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":6,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-02-26T18:12:30.000Z","date":"2021-02-24","kind":"other","acquired":false,"shares":1500000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 24, 2021, Third Rock Ventures III, L.P. (\"TRV III\") distributed for no consideration, 1,500,000 shares of Common Stock of the Issuer (the \"Shares\") to its limited partners and to Third Rock Ventures GP III, L.P. (\"TRV GP II\"), the general partner of TRV III, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP III distributed, for no consideration, the Shares it received in the distribution by TRV III to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 24, 2021, Third Rock Ventures III, L.P. (\"TRV III\") distributed for no consideration, 1,500,000 shares of Common Stock of the Issuer (the \"Shares\") to its limited partners and to Third Rock Ventures GP III, L.P. (\"TRV GP II\"), the general partner of TRV III, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP III distributed, for no consideration, the Shares it received in the distribution by TRV III to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by TRV III. The general partner of TRV III is TRV GP III. The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares"}],"balance_after":5524031,"source":{"system":"sec-edgar","filing":"0000899243-21-008465","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924321008465/doc4.xml","form_type":"4"}},{"id":2874785,"issuer":{"id":1156,"kind":"organization","name":"Nurix Therapeutics, Inc.","symbol":"NRIX"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":6,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-02-08T16:11:41.000Z","date":"2021-02-04","kind":"other","acquired":false,"shares":914216,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 4, 2021, Third Rock Ventures III, L.P. (\"TRV III\") distributed for no consideration, 914,216 shares of Common Stock of the Issuer (the \"Shares\") to its limited partners and to Third Rock Ventures GP III, L.P. (\"TRV GP III\"), the general partner of TRV III, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP III distributed, for no consideration, the Shares it received in the distribution by TRV III to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 4, 2021, Third Rock Ventures III, L.P. (\"TRV III\") distributed for no consideration, 914,216 shares of Common Stock of the Issuer (the \"Shares\") to its limited partners and to Third Rock Ventures GP III, L.P. (\"TRV GP III\"), the general partner of TRV III, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP III distributed, for no consideration, the Shares it received in the distribution by TRV III to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by TRV III. The general partner of TRV III is TRV GP III. The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":4508333,"source":{"system":"sec-edgar","filing":"0000899243-21-005161","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924321005161/doc4.xml","form_type":"4"}},{"id":2907353,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":6,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-14T20:44:58.000Z","date":"2021-01-14","kind":"sale","acquired":false,"shares":1965294,"price":41,"value":80577054.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.00 to $41.46, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (12)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of the reporting persons, except for TRV IV, disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F14","text":"Each of the reporting persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-002117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924321002117/doc4.xml","form_type":"4"}},{"id":2907352,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":6,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-14T20:44:58.000Z","date":"2021-01-13","kind":"sale","acquired":false,"shares":4782,"price":44.73,"value":213898.86,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.03 to $44.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (11)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of the reporting persons, except for TRV IV, disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F14","text":"Each of the reporting persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":1965294,"source":{"system":"sec-edgar","filing":"0000899243-21-002117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924321002117/doc4.xml","form_type":"4"}},{"id":2907351,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":6,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-14T20:44:58.000Z","date":"2021-01-13","kind":"sale","acquired":false,"shares":2791,"price":44,"value":122804.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.04 to $44.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (10)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of the reporting persons, except for TRV IV, disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F14","text":"Each of the reporting persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":1970076,"source":{"system":"sec-edgar","filing":"0000899243-21-002117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924321002117/doc4.xml","form_type":"4"}},{"id":2907350,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":6,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-14T20:44:58.000Z","date":"2021-01-13","kind":"sale","acquired":false,"shares":27650,"price":42.12,"value":1164618.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.96, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (9)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of the reporting persons, except for TRV IV, disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F14","text":"Each of the reporting persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":1972867,"source":{"system":"sec-edgar","filing":"0000899243-21-002117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924321002117/doc4.xml","form_type":"4"}},{"id":2907349,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":6,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-14T20:44:58.000Z","date":"2021-01-13","kind":"sale","acquired":false,"shares":5630,"price":41.08,"value":231280.4,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.00 to $41.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (8)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of the reporting persons, except for TRV IV, disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F14","text":"Each of the reporting persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":2000517,"source":{"system":"sec-edgar","filing":"0000899243-21-002117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924321002117/doc4.xml","form_type":"4"}},{"id":2907348,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":6,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-14T20:44:58.000Z","date":"2021-01-13","kind":"sale","acquired":false,"shares":805050,"price":40.01,"value":32210050.5,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.96, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (7)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of the reporting persons, except for TRV IV, disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F14","text":"Each of the reporting persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":2006147,"source":{"system":"sec-edgar","filing":"0000899243-21-002117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924321002117/doc4.xml","form_type":"4"}},{"id":2907347,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":6,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-14T20:44:58.000Z","date":"2021-01-13","kind":"sale","acquired":false,"shares":7412,"price":44.73,"value":331538.76,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.03 to $44.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (6)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\"). The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F14","text":"Each of the reporting persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":7739918,"source":{"system":"sec-edgar","filing":"0000899243-21-002117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924321002117/doc4.xml","form_type":"4"}},{"id":2907346,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":6,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-14T20:44:58.000Z","date":"2021-01-13","kind":"sale","acquired":false,"shares":4325,"price":44,"value":190300.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.04 to $44.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\"). The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F14","text":"Each of the reporting persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":7747330,"source":{"system":"sec-edgar","filing":"0000899243-21-002117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924321002117/doc4.xml","form_type":"4"}},{"id":2907345,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":6,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-14T20:44:58.000Z","date":"2021-01-13","kind":"sale","acquired":false,"shares":42860,"price":42.12,"value":1805263.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.96, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\"). The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F14","text":"Each of the reporting persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":7751655,"source":{"system":"sec-edgar","filing":"0000899243-21-002117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924321002117/doc4.xml","form_type":"4"}},{"id":2907344,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":6,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-14T20:44:58.000Z","date":"2021-01-13","kind":"sale","acquired":false,"shares":8727,"price":41.08,"value":358505.16,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.00 to $41.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\"). The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F14","text":"Each of the reporting persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":7794515,"source":{"system":"sec-edgar","filing":"0000899243-21-002117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924321002117/doc4.xml","form_type":"4"}},{"id":2907343,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":6,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-14T20:44:58.000Z","date":"2021-01-13","kind":"sale","acquired":false,"shares":1247873,"price":40.01,"value":49927398.73,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.96, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2)."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\"). The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F14","text":"Each of the reporting persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":7803242,"source":{"system":"sec-edgar","filing":"0000899243-21-002117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924321002117/doc4.xml","form_type":"4"}},{"id":2907342,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":6,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-01-14T20:44:58.000Z","date":"2021-01-12","kind":"sale","acquired":false,"shares":1500000,"price":40,"value":60000000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\"). The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F14","text":"Each of the reporting persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":9051115,"source":{"system":"sec-edgar","filing":"0000899243-21-002117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924321002117/doc4.xml","form_type":"4"}},{"id":2956757,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":6,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-04T18:45:19.000Z","date":"2020-12-02","kind":"other","acquired":false,"shares":1000000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 2, 2020, Third Rock Ventures III, L.P. (\"TRV III\") distributed for no consideration, 1,000,000 shares of Common Stock of the Issuer (the \"Shares\") to its limited partners and to Third Rock Ventures GP III, L.P. (\"TRV GP III\"), the general partner of TRV III, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP III distributed, for no consideration, the Shares it received in the distribution by TRV III to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 2, 2020, Third Rock Ventures III, L.P. (\"TRV III\") distributed for no consideration, 1,000,000 shares of Common Stock of the Issuer (the \"Shares\") to its limited partners and to Third Rock Ventures GP III, L.P. (\"TRV GP III\"), the general partner of TRV III, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP III distributed, for no consideration, the Shares it received in the distribution by TRV III to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by TRV III. The general partner of TRV III is TRV GP III. The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":7024031,"source":{"system":"sec-edgar","filing":"0000899243-20-032784","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924320032784/doc4.xml","form_type":"4"}},{"id":2970070,"issuer":{"id":15754,"kind":"organization","name":"Jounce Therapeutics, Inc.","symbol":"JNCE"},"owners":[{"id":135402,"kind":"organization","name":"Third Rock Ventures II, L.P.","position":1,"cik":"0001488495","reported_name":"Third Rock Ventures II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135403,"kind":"organization","name":"Third Rock Ventures GP II, L.P.","position":2,"cik":"0001614061","reported_name":"Third Rock Ventures GP II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105511,"kind":"organization","name":"TRV GP II, LLC","position":3,"cik":"0001614073","reported_name":"TRV GP II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":6,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-23T16:42:28.000Z","date":"2020-11-19","kind":"sale","acquired":false,"shares":15000,"price":7.005,"value":105075.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares are directly held by Third Rock Ventures II, L.P. (\"TRV II\"). The general partner of TRV II is Third Rock Ventures GP II, L.P. (\"TRV GP II\"). The general partner of TRV GP II is TRV GP II, LLC (\"TRV GP II LLC\"). The individual managers of TRV GP II LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP II, TRV GP II LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":9200349,"source":{"system":"sec-edgar","filing":"0000899243-20-031919","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924320031919/doc4.xml","form_type":"4"}},{"id":2973418,"issuer":{"id":15754,"kind":"organization","name":"Jounce Therapeutics, Inc.","symbol":"JNCE"},"owners":[{"id":135402,"kind":"organization","name":"Third Rock Ventures II, L.P.","position":1,"cik":"0001488495","reported_name":"Third Rock Ventures II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135403,"kind":"organization","name":"Third Rock Ventures GP II, L.P.","position":2,"cik":"0001614061","reported_name":"Third Rock Ventures GP II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105511,"kind":"organization","name":"TRV GP II, LLC","position":3,"cik":"0001614073","reported_name":"TRV GP II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":6,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-19T17:42:15.000Z","date":"2020-11-17","kind":"sale","acquired":false,"shares":15000,"price":7.2515,"value":108772.5,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares are directly held by Third Rock Ventures II, L.P. (\"TRV II\"). The general partner of TRV II is Third Rock Ventures GP II, L.P. (\"TRV GP II\"). The general partner of TRV GP II is TRV GP II, LLC (\"TRV GP II LLC\"). The individual managers of TRV GP II LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP II, TRV GP II LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":9215349,"source":{"system":"sec-edgar","filing":"0000899243-20-031680","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924320031680/doc4.xml","form_type":"4"}},{"id":2981582,"issuer":{"id":15754,"kind":"organization","name":"Jounce Therapeutics, Inc.","symbol":"JNCE"},"owners":[{"id":135402,"kind":"organization","name":"Third Rock Ventures II, L.P.","position":1,"cik":"0001488495","reported_name":"Third Rock Ventures II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135403,"kind":"organization","name":"Third Rock Ventures GP II, L.P.","position":2,"cik":"0001614061","reported_name":"Third Rock Ventures GP II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105511,"kind":"organization","name":"TRV GP II, LLC","position":3,"cik":"0001614073","reported_name":"TRV GP II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":6,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-13T20:26:48.000Z","date":"2020-11-11","kind":"other","acquired":false,"shares":1000000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 11, 2020, Third Rock Ventures II, L.P. (\"TRV II\") distributed for no consideration, 1,000,000 shares of Common Stock of the Issuer (the \"Shares\") to its limited partners and to Third Rock Ventures GP II, L.P. (\"TRV GP II\"), the general partner of TRV II, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP II distributed, for no consideration, the Shares it received in the distribution by TRV II to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 11, 2020, Third Rock Ventures II, L.P. (\"TRV II\") distributed for no consideration, 1,000,000 shares of Common Stock of the Issuer (the \"Shares\") to its limited partners and to Third Rock Ventures GP II, L.P. (\"TRV GP II\"), the general partner of TRV II, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP II distributed, for no consideration, the Shares it received in the distribution by TRV II to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by TRV II. The general partner of TRV II is TRV GP II. The general partner of TRV GP II is TRV GP II, LLC (\"TRV GP II LLC\"). The individual managers of TRV GP II LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP II, TRV GP II LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":9230349,"source":{"system":"sec-edgar","filing":"0000899243-20-031066","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924320031066/doc4.xml","form_type":"4"}},{"id":3033339,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":6,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-09-11T16:11:36.000Z","date":"2020-09-09","kind":"other","acquired":false,"shares":1000000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On September 9, 2020, Third Rock Ventures III, L.P. (\"TRV III\") distributed for no consideration, 1,000,000 shares of Common Stock of the Issuer (the \"Shares\") to its limited partners and to Third Rock Ventures GP III, L.P. (\"TRV GP III\"), the general partner of TRV III, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP III distributed, for no consideration, the Shares it received in the distribution by TRV III to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 9, 2020, Third Rock Ventures III, L.P. (\"TRV III\") distributed for no consideration, 1,000,000 shares of Common Stock of the Issuer (the \"Shares\") to its limited partners and to Third Rock Ventures GP III, L.P. (\"TRV GP III\"), the general partner of TRV III, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP III distributed, for no consideration, the Shares it received in the distribution by TRV III to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by TRV III. The general partner of TRV III is TRV GP III. The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of these shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":8024031,"source":{"system":"sec-edgar","filing":"0000899243-20-024900","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924320024900/doc4.xml","form_type":"4"}},{"id":3074242,"issuer":{"id":1156,"kind":"organization","name":"Nurix Therapeutics, Inc.","symbol":"NRIX"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":6,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Preferred Stock","published_at":"2020-07-29T21:19:31.000Z","date":"2020-07-28","kind":"exercise","acquired":false,"shares":39216,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A-2 and Series B Preferred Stock automatically converted into shares of the Issuer's common stock on a one-for-one basis immediately upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A-2 and Series B Preferred Stock automatically converted into shares of the Issuer's common stock on a one-for-one basis immediately upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A-2 and Series B Preferred Stock automatically converted into shares of the Issuer's common stock on a one-for-one basis immediately upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\"). The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of these shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":39216},"source":{"system":"sec-edgar","filing":"0000899243-20-020684","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924320020684/doc4.xml","form_type":"4"}},{"id":3074241,"issuer":{"id":1156,"kind":"organization","name":"Nurix Therapeutics, Inc.","symbol":"NRIX"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":6,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2020-07-29T21:19:31.000Z","date":"2020-07-28","kind":"exercise","acquired":false,"shares":4508333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A-2 and Series B Preferred Stock automatically converted into shares of the Issuer's common stock on a one-for-one basis immediately upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A-2 and Series B Preferred Stock automatically converted into shares of the Issuer's common stock on a one-for-one basis immediately upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A-2 and Series B Preferred Stock automatically converted into shares of the Issuer's common stock on a one-for-one basis immediately upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\"). The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of these shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4508333},"source":{"system":"sec-edgar","filing":"0000899243-20-020684","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924320020684/doc4.xml","form_type":"4"}},{"id":3074240,"issuer":{"id":1156,"kind":"organization","name":"Nurix Therapeutics, Inc.","symbol":"NRIX"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":6,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-2 Preferred Stock","published_at":"2020-07-29T21:19:31.000Z","date":"2020-07-28","kind":"exercise","acquired":false,"shares":875000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A-2 and Series B Preferred Stock automatically converted into shares of the Issuer's common stock on a one-for-one basis immediately upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A-2 and Series B Preferred Stock automatically converted into shares of the Issuer's common stock on a one-for-one basis immediately upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A-2 and Series B Preferred Stock automatically converted into shares of the Issuer's common stock on a one-for-one basis immediately upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\"). The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of these shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":875000},"source":{"system":"sec-edgar","filing":"0000899243-20-020684","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924320020684/doc4.xml","form_type":"4"}},{"id":3074239,"issuer":{"id":1156,"kind":"organization","name":"Nurix Therapeutics, Inc.","symbol":"NRIX"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":6,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-29T21:19:31.000Z","date":"2020-07-28","kind":"exercise","acquired":true,"shares":39216,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A-2 and Series B Preferred Stock automatically converted into shares of the Issuer's common stock on a one-for-one basis immediately upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\"). The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of these shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":5422549,"source":{"system":"sec-edgar","filing":"0000899243-20-020684","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924320020684/doc4.xml","form_type":"4"}},{"id":3074238,"issuer":{"id":1156,"kind":"organization","name":"Nurix Therapeutics, Inc.","symbol":"NRIX"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":6,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-29T21:19:31.000Z","date":"2020-07-28","kind":"exercise","acquired":true,"shares":4508333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A-2 and Series B Preferred Stock automatically converted into shares of the Issuer's common stock on a one-for-one basis immediately upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\"). The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of these shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":5383333,"source":{"system":"sec-edgar","filing":"0000899243-20-020684","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924320020684/doc4.xml","form_type":"4"}},{"id":3074237,"issuer":{"id":1156,"kind":"organization","name":"Nurix Therapeutics, Inc.","symbol":"NRIX"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":6,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-29T21:19:31.000Z","date":"2020-07-28","kind":"exercise","acquired":true,"shares":875000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A-2 and Series B Preferred Stock automatically converted into shares of the Issuer's common stock on a one-for-one basis immediately upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\"). The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of these shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":875000,"source":{"system":"sec-edgar","filing":"0000899243-20-020684","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924320020684/doc4.xml","form_type":"4"}},{"id":3079018,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":6,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2020-07-21T19:23:58.000Z","date":"2020-07-20","kind":"exercise","acquired":false,"shares":61881,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each share of Series B Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Each share of Series B Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each share of Series B Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Each share of Series B Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of the reporting persons, except for TRV IV, disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Each share of Series B Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Each of the reporting persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":17427},"source":{"system":"sec-edgar","filing":"0000899243-20-019850","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924320019850/doc4.xml","form_type":"4"}},{"id":3079017,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":6,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2020-07-21T19:23:58.000Z","date":"2020-07-20","kind":"exercise","acquired":false,"shares":61881,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each share of Series B Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Each share of Series B Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each share of Series B Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Each share of Series B Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of the reporting persons, except for TRV III, disclaims beneficial ownership of these shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"Each share of Series B Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F7","text":"Each of the reporting persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":17427},"source":{"system":"sec-edgar","filing":"0000899243-20-019850","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924320019850/doc4.xml","form_type":"4"}},{"id":3079016,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":6,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2020-07-21T19:23:58.000Z","date":"2020-07-20","kind":"exercise","acquired":false,"shares":9920455,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Series A Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series A Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Series A Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Series A Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each share of Series A Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of the reporting persons, except for TRV IV, disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Each of the reporting persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2793770},"source":{"system":"sec-edgar","filing":"0000899243-20-019850","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924320019850/doc4.xml","form_type":"4"}},{"id":3079015,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":6,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2020-07-21T19:23:58.000Z","date":"2020-07-20","kind":"exercise","acquired":false,"shares":35404286,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Series A Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series A Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Series A Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Series A Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of the reporting persons, except for TRV III, disclaims beneficial ownership of these shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each share of Series A Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F7","text":"Each of the reporting persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":9970454},"source":{"system":"sec-edgar","filing":"0000899243-20-019850","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924320019850/doc4.xml","form_type":"4"}},{"id":3079014,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":6,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-21T19:23:58.000Z","date":"2020-07-20","kind":"exercise","acquired":true,"shares":17427,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of the reporting persons, except for TRV IV, disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Each share of Series B Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Each of the reporting persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":2811197,"source":{"system":"sec-edgar","filing":"0000899243-20-019850","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924320019850/doc4.xml","form_type":"4"}},{"id":3079013,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":6,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-21T19:23:58.000Z","date":"2020-07-20","kind":"exercise","acquired":true,"shares":17427,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of the reporting persons, except for TRV III, disclaims beneficial ownership of these shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"Each share of Series B Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F7","text":"Each of the reporting persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":9987881,"source":{"system":"sec-edgar","filing":"0000899243-20-019850","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924320019850/doc4.xml","form_type":"4"}},{"id":3079012,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":6,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-21T19:23:58.000Z","date":"2020-07-20","kind":"exercise","acquired":true,"shares":2793770,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each share of Series A Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares are directly held by Third Rock Ventures IV, L.P. (\"TRV IV\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of the reporting persons, except for TRV IV, disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Each of the reporting persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":2793770,"source":{"system":"sec-edgar","filing":"0000899243-20-019850","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924320019850/doc4.xml","form_type":"4"}},{"id":3079011,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":6,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-21T19:23:58.000Z","date":"2020-07-20","kind":"exercise","acquired":true,"shares":9970454,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of the reporting persons, except for TRV III, disclaims beneficial ownership of these shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Each share of Series A Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") on a 1-for-3.55092 basis upon the closing of the Issuer's initial public offering on July 20, 2020 and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F7","text":"Each of the reporting persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":9970454,"source":{"system":"sec-edgar","filing":"0000899243-20-019850","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924320019850/doc4.xml","form_type":"4"}},{"id":3091893,"issuer":{"id":15754,"kind":"organization","name":"Jounce Therapeutics, Inc.","symbol":"JNCE"},"owners":[{"id":104809,"kind":"person","name":"Tepper Robert I","position":1,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-02T19:37:10.000Z","date":"2020-06-26","kind":"grant","acquired":true,"shares":15700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The original Form 4 filed on June 29, 2020 erroneously reported 13,550 shares of common stock subject to the stock option. This amendment is being filed to disclose the correct number of shares subject to the reported stock option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in equal quarterly installments during the four quarters following the grant date, provided that if the Issuer's 2021 annual meeting of stockholders occurs before the one-year anniversary of the grant date, the unvested portion of the option will vest as of the date of such annual meeting, subject in each case to the Reporting Person's continued service on the Issuer's board of directors."}],"balance_after":15700,"derivative":{"exercise_price":7.58,"expiration_date":"2030-06-26","underlying":"Common Stock","underlying_shares":15700},"source":{"system":"sec-edgar","filing":"0001640455-20-000091","document":"wf-form4a_159373301056979.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640455/000164045520000091/wf-form4a_159373301056979.xml","form_type":"4/A","original_submission_date":"2020-06-29"}},{"id":3097558,"issuer":{"id":15754,"kind":"organization","name":"Jounce Therapeutics, Inc.","symbol":"JNCE"},"owners":[{"id":104809,"kind":"person","name":"Tepper Robert I","position":1,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-29T19:36:45.000Z","date":"2020-06-26","kind":"grant","acquired":true,"shares":13550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in equal quarterly installments during the four quarters following the grant date, provided that if the Issuer's 2021 annual meeting of stockholders occurs before the one-year anniversary of the grant date, the unvested portion of the option will vest as of the date of such annual meeting, subject in each case to the Reporting Person's continued service on the Issuer's board of directors."}],"balance_after":13550,"derivative":{"exercise_price":7.58,"expiration_date":"2030-06-26","underlying":"Common Stock","underlying_shares":13550},"source":{"system":"sec-edgar","filing":"0001640455-20-000075","document":"wf-form4_159347379104130.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640455/000164045520000075/wf-form4_159347379104130.xml","form_type":"4"}},{"id":3116885,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":6,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2020-06-09T21:01:30.000Z","date":"2020-06-05","kind":"exercise","acquired":false,"shares":15250000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Series A Preferred Stock converted into Common Stock on a 7.15-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Series A Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series A Preferred Stock converted into Common Stock on a 7.15-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Series A Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series A Preferred Stock converted into Common Stock on a 7.15-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Series A Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"These shares are directly held by Third Rock Ventures IV."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Each of Reporting Persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2132867},"source":{"system":"sec-edgar","filing":"0000899243-20-015874","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924320015874/doc4.xml","form_type":"4"}},{"id":3116884,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":6,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2020-06-09T21:01:30.000Z","date":"2020-06-05","kind":"exercise","acquired":false,"shares":39750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Series A Preferred Stock converted into Common Stock on a 7.15-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Series A Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series A Preferred Stock converted into Common Stock on a 7.15-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Series A Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series A Preferred Stock converted into Common Stock on a 7.15-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Series A Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These shares are directly held by TRV III."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III  LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of these shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F8","text":"Each of Reporting Persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5559440},"source":{"system":"sec-edgar","filing":"0000899243-20-015874","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924320015874/doc4.xml","form_type":"4"}},{"id":3116883,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":6,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-06-09T21:01:30.000Z","date":"2020-06-05","kind":"exercise","acquired":true,"shares":2132867,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents the total number of shares of Common Stock received by Third Rock Ventures IV, L.P. (\"TRV IV\") upon conversion of the preferred stock of the Issuer in connection with the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series A Preferred Stock converted into Common Stock on a 7.15-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Series A Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"These shares are directly held by Third Rock Ventures IV."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Each of Reporting Persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":2132867,"source":{"system":"sec-edgar","filing":"0000899243-20-015874","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924320015874/doc4.xml","form_type":"4"}},{"id":3116882,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":4,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":5,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":6,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73568,"kind":"organization","name":"Third Rock Ventures IV, L.P.","position":7,"cik":"0001688327","reported_name":"Third Rock Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73569,"kind":"organization","name":"Third Rock Ventures GP IV, L.P.","position":8,"cik":"0001688326","reported_name":"Third Rock Ventures GP IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73570,"kind":"organization","name":"TRV GP IV, LLC","position":9,"cik":"0001688325","reported_name":"TRV GP IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-06-09T21:01:30.000Z","date":"2020-06-05","kind":"exercise","acquired":true,"shares":5559440,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the total number of shares of Common Stock received by Third Rock Ventures III, L.P. (\"TRV III\") upon conversion of the preferred stock of the Issuer in connection with the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series A Preferred Stock converted into Common Stock on a 7.15-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Series A Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These shares are directly held by TRV III."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III  LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of these shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F8","text":"Each of Reporting Persons disclaims the existence of a Section 13(d) \"group\" as between the TRV III related parties and the TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties."}],"balance_after":5839160,"source":{"system":"sec-edgar","filing":"0000899243-20-015874","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924320015874/doc4.xml","form_type":"4"}},{"id":3159648,"issuer":{"id":149433,"kind":"organization","name":"Neon Therapeutics, Inc.","symbol":"NTGN"},"owners":[{"id":104809,"kind":"person","name":"Tepper Robert I","position":1,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-06T21:09:00.000Z","date":"2020-05-06","kind":"disposition_to_issuer","acquired":false,"shares":18500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, these options were cancelled for no consideration because these options had an exercise price per Share that was equal to or greater than the product of the volume weighted average price of one BioNTech ADS for the ten trading days immediately prior to the second business day prior to the day of the closing of the Merger, starting with the opening of trading on the first trading day to the closing of the second to last trading day prior to the day of the closing of the Merger, as reported by Bloomberg, multiplied by the Exchange Ratio (the \"Cash Merger Consideration\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, these options were cancelled for no consideration because these options had an exercise price per Share that was equal to or greater than the product of the volume weighted average price of one BioNTech ADS for the ten trading days immediately prior to the second business day prior to the day of the closing of the Merger, starting with the opening of trading on the first trading day to the closing of the second to last trading day prior to the day of the closing of the Merger, as reported by Bloomberg, multiplied by the Exchange Ratio (the \"Cash Merger Consideration\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, these options were cancelled for no consideration because these options had an exercise price per Share that was equal to or greater than the product of the volume weighted average price of one BioNTech ADS for the ten trading days immediately prior to the second business day prior to the day of the closing of the Merger, starting with the opening of trading on the first trading day to the closing of the second to last trading day prior to the day of the closing of the Merger, as reported by Bloomberg, multiplied by the Exchange Ratio (the \"Cash Merger Consideration\")."}],"balance_after":0,"derivative":{"exercise_price":4.64,"underlying":"Common Stock","underlying_shares":18500},"source":{"system":"sec-edgar","filing":"0001694187-20-000071","document":"wf-form4_158881372234616.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1694187/000169418720000071/wf-form4_158881372234616.xml","form_type":"4"}},{"id":3159647,"issuer":{"id":149433,"kind":"organization","name":"Neon Therapeutics, Inc.","symbol":"NTGN"},"owners":[{"id":104809,"kind":"person","name":"Tepper Robert I","position":1,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-06T21:09:00.000Z","date":"2020-05-06","kind":"disposition_to_issuer","acquired":false,"shares":14000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, these options were cancelled for no consideration because these options had an exercise price per Share that was equal to or greater than the product of the volume weighted average price of one BioNTech ADS for the ten trading days immediately prior to the second business day prior to the day of the closing of the Merger, starting with the opening of trading on the first trading day to the closing of the second to last trading day prior to the day of the closing of the Merger, as reported by Bloomberg, multiplied by the Exchange Ratio (the \"Cash Merger Consideration\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, these options were cancelled for no consideration because these options had an exercise price per Share that was equal to or greater than the product of the volume weighted average price of one BioNTech ADS for the ten trading days immediately prior to the second business day prior to the day of the closing of the Merger, starting with the opening of trading on the first trading day to the closing of the second to last trading day prior to the day of the closing of the Merger, as reported by Bloomberg, multiplied by the Exchange Ratio (the \"Cash Merger Consideration\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, these options were cancelled for no consideration because these options had an exercise price per Share that was equal to or greater than the product of the volume weighted average price of one BioNTech ADS for the ten trading days immediately prior to the second business day prior to the day of the closing of the Merger, starting with the opening of trading on the first trading day to the closing of the second to last trading day prior to the day of the closing of the Merger, as reported by Bloomberg, multiplied by the Exchange Ratio (the \"Cash Merger Consideration\")."}],"balance_after":0,"derivative":{"exercise_price":16,"underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001694187-20-000071","document":"wf-form4_158881372234616.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1694187/000169418720000071/wf-form4_158881372234616.xml","form_type":"4"}},{"id":3159646,"issuer":{"id":149433,"kind":"organization","name":"Neon Therapeutics, Inc.","symbol":"NTGN"},"owners":[{"id":104809,"kind":"person","name":"Tepper Robert I","position":1,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-06T21:09:00.000Z","date":"2020-05-06","kind":"disposition_to_issuer","acquired":false,"shares":9741636,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of January 15, 2020, by and among the Issuer, BioNTech SE (\"BioNTech\"), and Endor Lights, Inc. a direct wholly owned subsidiary of BioNTech (\"Merger Sub\"), pursuant to which Merger Sub merged with and into the Issuer (the \"Merger\") effective as of May 6, 2020 (the \"Effective Time\"). Immediately prior to the Effective Time, each issued and outstanding share of common stock of the Issuer (each, a \"Share\") was cancelled and converted into the right to receive 0.063 (the \"Exchange Ratio\") of American Depositary Shares of BioNTech (\"BioNTech ADS\") plus the right, if any, to receive cash in lieu of fractional shares of BioNTech ADSs into which such Shares would have been converted."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of January 15, 2020, by and among the Issuer, BioNTech SE (\"BioNTech\"), and Endor Lights, Inc. a direct wholly owned subsidiary of BioNTech (\"Merger Sub\"), pursuant to which Merger Sub merged with and into the Issuer (the \"Merger\") effective as of May 6, 2020 (the \"Effective Time\"). Immediately prior to the Effective Time, each issued and outstanding share of common stock of the Issuer (each, a \"Share\") was cancelled and converted into the right to receive 0.063 (the \"Exchange Ratio\") of American Depositary Shares of BioNTech (\"BioNTech ADS\") plus the right, if any, to receive cash in lieu of fractional shares of BioNTech ADSs into which such Shares would have been converted."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These Shares were directly held by TRV III. The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of the Shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such Shares."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001694187-20-000071","document":"wf-form4_158881372234616.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694187/000169418720000071/wf-form4_158881372234616.xml","form_type":"4"}},{"id":3267118,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135402,"kind":"organization","name":"Third Rock Ventures II, L.P.","position":4,"cik":"0001488495","reported_name":"Third Rock Ventures II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135403,"kind":"organization","name":"Third Rock Ventures GP II, L.P.","position":5,"cik":"0001614061","reported_name":"Third Rock Ventures GP II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105511,"kind":"organization","name":"TRV GP II, LLC","position":6,"cik":"0001614073","reported_name":"TRV GP II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":7,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":8,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":9,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2020-02-18T17:21:49.000Z","date":"2020-02-18","kind":"exercise","acquired":false,"shares":1909317,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"These shares are directly held by TRV II. The general partner of TRV II is Third Rock Ventures GP II, L.P. (\"TRV GP II\"). The general partner of TRV GP II is TRV GP II, LLC (\"TRV GP II LLC\"). The individual managers of TRV GP II LLC are Levin, Starr and Tepper. Each of TRV GP II, TRV GP II LLC, Levin, Starr and Tepper disclaims beneficial ownership of these shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1909317},"source":{"system":"sec-edgar","filing":"0000899243-20-004930","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924320004930/doc4.xml","form_type":"4"}},{"id":3267117,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135402,"kind":"organization","name":"Third Rock Ventures II, L.P.","position":4,"cik":"0001488495","reported_name":"Third Rock Ventures II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135403,"kind":"organization","name":"Third Rock Ventures GP II, L.P.","position":5,"cik":"0001614061","reported_name":"Third Rock Ventures GP II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105511,"kind":"organization","name":"TRV GP II, LLC","position":6,"cik":"0001614073","reported_name":"TRV GP II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":7,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":8,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":9,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2020-02-18T17:21:49.000Z","date":"2020-02-18","kind":"exercise","acquired":false,"shares":49879,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These shares are directly held by TRV III. The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of these shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":49879},"source":{"system":"sec-edgar","filing":"0000899243-20-004930","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924320004930/doc4.xml","form_type":"4"}},{"id":3267116,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135402,"kind":"organization","name":"Third Rock Ventures II, L.P.","position":4,"cik":"0001488495","reported_name":"Third Rock Ventures II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135403,"kind":"organization","name":"Third Rock Ventures GP II, L.P.","position":5,"cik":"0001614061","reported_name":"Third Rock Ventures GP II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105511,"kind":"organization","name":"TRV GP II, LLC","position":6,"cik":"0001614073","reported_name":"TRV GP II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":7,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":8,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":9,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2020-02-18T17:21:49.000Z","date":"2020-02-18","kind":"exercise","acquired":false,"shares":342505,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These shares are directly held by TRV III. The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of these shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":342505},"source":{"system":"sec-edgar","filing":"0000899243-20-004930","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924320004930/doc4.xml","form_type":"4"}},{"id":3267115,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135402,"kind":"organization","name":"Third Rock Ventures II, L.P.","position":4,"cik":"0001488495","reported_name":"Third Rock Ventures II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135403,"kind":"organization","name":"Third Rock Ventures GP II, L.P.","position":5,"cik":"0001614061","reported_name":"Third Rock Ventures GP II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105511,"kind":"organization","name":"TRV GP II, LLC","position":6,"cik":"0001614073","reported_name":"TRV GP II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":7,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":8,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":9,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2020-02-18T17:21:49.000Z","date":"2020-02-18","kind":"exercise","acquired":false,"shares":8220641,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These shares are directly held by TRV III. The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of these shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8220641},"source":{"system":"sec-edgar","filing":"0000899243-20-004930","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924320004930/doc4.xml","form_type":"4"}},{"id":3267114,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135402,"kind":"organization","name":"Third Rock Ventures II, L.P.","position":4,"cik":"0001488495","reported_name":"Third Rock Ventures II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135403,"kind":"organization","name":"Third Rock Ventures GP II, L.P.","position":5,"cik":"0001614061","reported_name":"Third Rock Ventures GP II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105511,"kind":"organization","name":"TRV GP II, LLC","position":6,"cik":"0001614073","reported_name":"TRV GP II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":7,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":8,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":9,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-02-18T17:21:49.000Z","date":"2020-02-18","kind":"exercise","acquired":true,"shares":1909317,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the total number of shares of Common Stock received by Third Rock Ventures II, L.P. (\"TRV II\") upon conversion of the Series B Preferred Stock of the Issuer in connection with the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These shares are directly held by TRV III. The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of these shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":1909317,"source":{"system":"sec-edgar","filing":"0000899243-20-004930","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924320004930/doc4.xml","form_type":"4"}},{"id":3267113,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135402,"kind":"organization","name":"Third Rock Ventures II, L.P.","position":4,"cik":"0001488495","reported_name":"Third Rock Ventures II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":135403,"kind":"organization","name":"Third Rock Ventures GP II, L.P.","position":5,"cik":"0001614061","reported_name":"Third Rock Ventures GP II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105511,"kind":"organization","name":"TRV GP II, LLC","position":6,"cik":"0001614073","reported_name":"TRV GP II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":7,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":8,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":9,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-02-18T17:21:49.000Z","date":"2020-02-18","kind":"exercise","acquired":true,"shares":8613025,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the total number of shares of Common Stock received by Third Rock Ventures III, L.P. (\"TRV III\") upon conversion of the Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock of the Issuer in connection with the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These shares are directly held by TRV III. The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of these shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":9024031,"source":{"system":"sec-edgar","filing":"0000899243-20-004930","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924320004930/doc4.xml","form_type":"4"}},{"id":3457864,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2019-07-22T16:34:59.000Z","date":"2019-07-22","kind":"exercise","acquired":false,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On July 22, 2019, the Series A Preferred Stock converted into Common Stock on a seven-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"shares","element":"transactionShares","label":"F2","text":"As of the date of this filing, Third Rock Ventures IV, L.P. (\"TRV IV\") holds 2,261,904 shares of Common Stock issued upon conversion of 15,833,333 shares of Series A Preferred Stock. The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Abbie Celniker, Ph.D., Tepper, Alexis Borisy, Craig Muir and Cary Pfeffer, M.D. are the managing members of TRV IV LLC who collectively make voting and investment decisions with respect to shares held by TRV IV LP.  Tepper disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 22, 2019, the Series A Preferred Stock converted into Common Stock on a seven-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 22, 2019, the Series A Preferred Stock converted into Common Stock on a seven-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"As of the date of this filing, Third Rock Ventures IV, L.P. (\"TRV IV\") holds 2,261,904 shares of Common Stock issued upon conversion of 15,833,333 shares of Series A Preferred Stock. The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Abbie Celniker, Ph.D., Tepper, Alexis Borisy, Craig Muir and Cary Pfeffer, M.D. are the managing members of TRV IV LLC who collectively make voting and investment decisions with respect to shares held by TRV IV LP.  Tepper disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\"). The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III LP\"). The general partner of TRV GP III LP is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\").  Each of TRV GP III LP, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":0},"source":{"system":"sec-edgar","filing":"0000899243-19-020026","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1192603/000089924319020026/doc4.xml","form_type":"4"}},{"id":3457863,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2019-07-22T16:34:59.000Z","date":"2019-07-22","kind":"exercise","acquired":false,"shares":39166667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On July 22, 2019, the Series A Preferred Stock converted into Common Stock on a seven-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 22, 2019, the Series A Preferred Stock converted into Common Stock on a seven-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 22, 2019, the Series A Preferred Stock converted into Common Stock on a seven-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\"). The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III LP\"). The general partner of TRV GP III LP is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\").  Each of TRV GP III LP, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5595238},"source":{"system":"sec-edgar","filing":"0000899243-19-020026","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1192603/000089924319020026/doc4.xml","form_type":"4"}},{"id":3457862,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-07-22T16:34:59.000Z","date":"2019-07-22","kind":"purchase","acquired":true,"shares":81250,"price":16,"value":1300000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"As of the date of this filing, Third Rock Ventures IV, L.P. (\"TRV IV\") holds 2,261,904 shares of Common Stock issued upon conversion of 15,833,333 shares of Series A Preferred Stock. The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Abbie Celniker, Ph.D., Tepper, Alexis Borisy, Craig Muir and Cary Pfeffer, M.D. are the managing members of TRV IV LLC who collectively make voting and investment decisions with respect to shares held by TRV IV LP.  Tepper disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\"). The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III LP\"). The general partner of TRV GP III LP is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\").  Each of TRV GP III LP, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":5962202,"source":{"system":"sec-edgar","filing":"0000899243-19-020026","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1192603/000089924319020026/doc4.xml","form_type":"4"}},{"id":3457861,"issuer":{"id":5969,"kind":"organization","name":"Fulcrum Therapeutics, Inc."},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-07-22T16:34:59.000Z","date":"2019-07-22","kind":"exercise","acquired":true,"shares":5595238,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On July 22, 2019, the Series A Preferred Stock converted into Common Stock on a seven-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"As of the date of this filing, Third Rock Ventures IV, L.P. (\"TRV IV\") holds 2,261,904 shares of Common Stock issued upon conversion of 15,833,333 shares of Series A Preferred Stock. The general partner of TRV IV is Third Rock Ventures GP IV, L.P. (\"TRV GP IV\"). The general partner of TRV GP IV is TRV GP IV, LLC (\"TRV GP IV LLC\"). Abbie Celniker, Ph.D., Tepper, Alexis Borisy, Craig Muir and Cary Pfeffer, M.D. are the managing members of TRV IV LLC who collectively make voting and investment decisions with respect to shares held by TRV IV LP.  Tepper disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The shares are directly held by Third Rock Ventures III, L.P. (\"TRV III\"). The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III LP\"). The general partner of TRV GP III LP is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\").  Each of TRV GP III LP, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":5880952,"source":{"system":"sec-edgar","filing":"0000899243-19-020026","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1192603/000089924319020026/doc4.xml","form_type":"4"}},{"id":3476923,"issuer":{"id":149433,"kind":"organization","name":"Neon Therapeutics, Inc.","symbol":"NTGN"},"owners":[{"id":104809,"kind":"person","name":"Tepper Robert I","position":1,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-06-27T08:27:58.000Z","date":"2019-06-25","kind":"grant","acquired":true,"shares":18500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 25, 2019 with respect to 18,500 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant."}],"balance_after":18500,"derivative":{"exercise_price":4.64,"expiration_date":"2029-06-24","underlying":"Common Stock","underlying_shares":18500},"source":{"system":"sec-edgar","filing":"0001694187-19-000053","document":"wf-form4_156163846266780.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694187/000169418719000053/wf-form4_156163846266780.xml","form_type":"4"}},{"id":3491395,"issuer":{"id":15754,"kind":"organization","name":"Jounce Therapeutics, Inc.","symbol":"JNCE"},"owners":[{"id":104809,"kind":"person","name":"Tepper Robert I","position":1,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-13T10:32:54.000Z","date":"2019-06-12","kind":"grant","acquired":true,"shares":15700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in equal quarterly installments during the four quarters following the grant date, provided that if the Issuer's 2020 annual meeting of stockholders occurs before the one-year anniversary of the grant date, the unvested portion of the option will vest as of the date of such annual meeting, subject in each case to the Reporting Person's continued service on the Issuer's board of directors."}],"balance_after":15700,"derivative":{"exercise_price":4.46,"expiration_date":"2029-06-12","underlying":"Common Stock","underlying_shares":15700},"source":{"system":"sec-edgar","filing":"0001640455-19-000060","document":"wf-form4_156043635978124.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640455/000164045519000060/wf-form4_156043635978124.xml","form_type":"4"}},{"id":3495667,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":104809,"kind":"person","name":"Tepper Robert I","position":1,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-10T16:47:23.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":13171,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 6, 2019 and will vest as to all shares underlying the option on June 6, 2020, subject to continued service."}],"balance_after":13171,"derivative":{"exercise_price":9.12,"expiration_date":"2029-06-05","underlying":"Common Stock","underlying_shares":13171},"source":{"system":"sec-edgar","filing":"0000899243-19-016202","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434418/000089924319016202/doc4.xml","form_type":"4"}},{"id":3497212,"issuer":{"id":130904,"kind":"organization","name":"Allena Pharmaceuticals, Inc.","symbol":"ALNA"},"owners":[{"id":104809,"kind":"person","name":"Tepper Robert I","position":1,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-07T09:20:40.000Z","date":"2019-06-05","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option shall vest in full (i.e., in single installment) upon the earlier to occur of the first anniversary of the date of grant or the date of the next annual meeting of shareholders."}],"balance_after":14000,"derivative":{"exercise_price":5.59,"expiration_date":"2029-06-04","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001209191-19-035400","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1624658/000120919119035400/doc4.xml","form_type":"4"}},{"id":3811629,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":117227,"kind":"organization","name":"Third Rock Ventures III, L.P.","position":1,"cik":"0001569705","reported_name":"Third Rock Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":117228,"kind":"organization","name":"Third Rock Ventures GP III, L.P.","position":2,"cik":"0001637300","reported_name":"Third Rock Ventures GP III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104800,"kind":"organization","name":"TRV GP III, LLC","position":3,"cik":"0001637299","reported_name":"TRV GP III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-09-19T21:41:38.000Z","date":"2018-09-19","kind":"other","acquired":false,"shares":1500000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a Rule 10b5-1 trading plan adopted by Third Rock Ventures III, L.P. (\"TRV III\"), Third Rock Ventures GP III, L.P. (\"TRV GP III\") and TRV GP III, LLC (\"TRV GP III LLC\"), TRV III distributed on September 19, 2018, for no consideration, 1,500,000 shares of Common Stock of the Issuer (the \"Shares\") to its limited partners and to TRV GP III, the general partner of TRV III, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP III distributed, for no consideration, the Shares it received in the distribution by TRV III to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to a Rule 10b5-1 trading plan adopted by Third Rock Ventures III, L.P. (\"TRV III\"), Third Rock Ventures GP III, L.P. (\"TRV GP III\") and TRV GP III, LLC (\"TRV GP III LLC\"), TRV III distributed on September 19, 2018, for no consideration, 1,500,000 shares of Common Stock of the Issuer (the \"Shares\") to its limited partners and to TRV GP III, the general partner of TRV III, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP III distributed, for no consideration, the Shares it received in the distribution by TRV III to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by TRV III. The general partner of TRV III is TRV GP III. The general partner of TRV GP III is TRV GP III LLC. The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":6391176,"source":{"system":"sec-edgar","filing":"0000899243-18-024777","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000089924318024777/doc4.xml","form_type":"4"}},{"id":3827477,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":163840,"kind":"organization","name":"THIRD ROCK VENTURES LP","position":1,"cik":"0001408591","reported_name":"THIRD ROCK VENTURES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":163841,"kind":"organization","name":"Third Rock Ventures GP, L.P.","position":2,"cik":"0001578976","reported_name":"Third Rock Ventures GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105938,"kind":"organization","name":"TRV GP, LLC","position":3,"cik":"0001578973","reported_name":"TRV GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105515,"kind":"person","name":"STARR KEVIN P","position":4,"cik":"0001192603","reported_name":"STARR KEVIN P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104809,"kind":"person","name":"Tepper Robert I","position":5,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105517,"kind":"person","name":"Levin Mark J","position":6,"cik":"0001180428","reported_name":"LEVIN MARK J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-09-04T16:06:06.000Z","date":"2018-08-30","kind":"other","acquired":false,"shares":1000000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a Rule 10b5-1 trading plan adopted by Third Rock Ventures, L.P. (\"TRV\"), Third Rock Ventures GP, L.P. (\"TRV GP\") and TRV GP, LLC (\"TRV GP LLC\"), TRV distributed on August 30, 2018, for no consideration, 1,000,000 shares of Common Stock of the Issuer (the \"Shares\") to its limited partners and to TRV GP, the general partner of TRV, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP distributed, for no consideration, the Shares it received in the distribution by TRV to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to a Rule 10b5-1 trading plan adopted by Third Rock Ventures, L.P. (\"TRV\"), Third Rock Ventures GP, L.P. (\"TRV GP\") and TRV GP, LLC (\"TRV GP LLC\"), TRV distributed on August 30, 2018, for no consideration, 1,000,000 shares of Common Stock of the Issuer (the \"Shares\") to its limited partners and to TRV GP, the general partner of TRV, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP distributed, for no consideration, the Shares it received in the distribution by TRV to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are directly held by TRV. The general partner of TRV is TRV GP. The general partner of TRV GP is TRV GP LLC. The individual managers of TRV GP LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP, TRV GP LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":2981437,"source":{"system":"sec-edgar","filing":"0000899243-18-023708","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180428/000089924318023708/doc4.xml","form_type":"4"}},{"id":3833804,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":104809,"kind":"person","name":"Tepper Robert I","position":1,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2018-08-24T16:05:29.000Z","date":"2018-08-22","kind":"other","acquired":false,"shares":51032,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Funds"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The warrant was fully exercisable upon grant."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are directly held by Third Rock Ventures, L.P. (\"TRV\"). The general partner of TRV is Third Rock Ventures GP, L.P. (\"TRV GP\"). The general partner of TRV GP is TRV GP, LLC (\"TRV GP LLC\"). The individual managers of TRV GP LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP, TRV GP LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":0,"derivative":{"exercise_price":1.55,"expiration_date":"2021-05-24","underlying":"Common Stock","underlying_shares":51032},"source":{"system":"sec-edgar","filing":"0000899243-18-023214","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434418/000089924318023214/doc4.xml","form_type":"4"}},{"id":3833803,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":104809,"kind":"person","name":"Tepper Robert I","position":1,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-24T16:05:29.000Z","date":"2018-08-22","kind":"other","acquired":true,"shares":51032,"price":1.55,"value":79099.6,"ownership":{"direct":false,"nature":"By Funds"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are directly held by Third Rock Ventures, L.P. (\"TRV\"). The general partner of TRV is Third Rock Ventures GP, L.P. (\"TRV GP\"). The general partner of TRV GP is TRV GP, LLC (\"TRV GP LLC\"). The individual managers of TRV GP LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP, TRV GP LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are directly held by Third Rock Ventures, L.P. (\"TRV\"). The general partner of TRV is Third Rock Ventures GP, L.P. (\"TRV GP\"). The general partner of TRV GP is TRV GP, LLC (\"TRV GP LLC\"). The individual managers of TRV GP LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP, TRV GP LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":3034083,"source":{"system":"sec-edgar","filing":"0000899243-18-023214","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434418/000089924318023214/doc4.xml","form_type":"4"}},{"id":3862195,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":104809,"kind":"person","name":"Tepper Robert I","position":1,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series F Preferred Stock","published_at":"2018-07-24T19:15:51.000Z","date":"2018-07-23","kind":"exercise","acquired":false,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Funds"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On July 23, 2018, the Series A, Series B, Series D, Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A, Series B, Series C, Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 23, 2018, the Series A, Series B, Series D, Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A, Series B, Series C, Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 23, 2018, the Series A, Series B, Series D, Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A, Series B, Series C, Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are directly held by Third Rock Ventures, L.P. (\"TRV\"). The general partner of TRV is Third Rock Ventures GP, L.P. (\"TRV GP\"). The general partner of TRV GP is TRV GP, LLC (\"TRV GP LLC\"). Dr. Tepper is an individual manager of TRV GP LLC. Dr. Tepper disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such shares."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":90840},"source":{"system":"sec-edgar","filing":"0000899243-18-020533","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1434418/000089924318020533/doc4.xml","form_type":"4"}},{"id":3862194,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":104809,"kind":"person","name":"Tepper Robert I","position":1,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E-1 Preferred Stock","published_at":"2018-07-24T19:15:51.000Z","date":"2018-07-23","kind":"exercise","acquired":false,"shares":3107930,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Funds"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On July 23, 2018, the Series A, Series B, Series D, Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A, Series B, Series C, Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 23, 2018, the Series A, Series B, Series D, Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A, Series B, Series C, Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 23, 2018, the Series A, Series B, Series D, Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A, Series B, Series C, Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are directly held by Third Rock Ventures, L.P. (\"TRV\"). The general partner of TRV is Third Rock Ventures GP, L.P. (\"TRV GP\"). The general partner of TRV GP is TRV GP, LLC (\"TRV GP LLC\"). Dr. Tepper is an individual manager of TRV GP LLC. Dr. Tepper disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such shares."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":282308},"source":{"system":"sec-edgar","filing":"0000899243-18-020533","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1434418/000089924318020533/doc4.xml","form_type":"4"}},{"id":3862193,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":104809,"kind":"person","name":"Tepper Robert I","position":1,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E Preferred Stock","published_at":"2018-07-24T19:15:51.000Z","date":"2018-07-23","kind":"exercise","acquired":false,"shares":2285640,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Funds"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On July 23, 2018, the Series A, Series B, Series D, Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A, Series B, Series C, Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 23, 2018, the Series A, Series B, Series D, Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A, Series B, Series C, Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 23, 2018, the Series A, Series B, Series D, Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A, Series B, Series C, Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are directly held by Third Rock Ventures, L.P. (\"TRV\"). The general partner of TRV is Third Rock Ventures GP, L.P. (\"TRV GP\"). The general partner of TRV GP is TRV GP, LLC (\"TRV GP LLC\"). Dr. Tepper is an individual manager of TRV GP LLC. Dr. Tepper disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such shares."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":266934},"source":{"system":"sec-edgar","filing":"0000899243-18-020533","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1434418/000089924318020533/doc4.xml","form_type":"4"}},{"id":3862192,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":104809,"kind":"person","name":"Tepper Robert I","position":1,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Preferred Stock","published_at":"2018-07-24T19:15:51.000Z","date":"2018-07-23","kind":"exercise","acquired":false,"shares":1086411,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Funds"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On July 23, 2018, the Series A, Series B, Series D, Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A, Series B, Series C, Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 23, 2018, the Series A, Series B, Series D, Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A, Series B, Series C, Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 23, 2018, the Series A, Series B, Series D, Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A, Series B, Series C, Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are directly held by Third Rock Ventures, L.P. (\"TRV\"). The general partner of TRV is Third Rock Ventures GP, L.P. (\"TRV GP\"). The general partner of TRV GP is TRV GP, LLC (\"TRV GP LLC\"). Dr. Tepper is an individual manager of TRV GP LLC. Dr. Tepper disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such shares."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":98683},"source":{"system":"sec-edgar","filing":"0000899243-18-020533","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1434418/000089924318020533/doc4.xml","form_type":"4"}},{"id":3862191,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":104809,"kind":"person","name":"Tepper Robert I","position":1,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2018-07-24T19:15:51.000Z","date":"2018-07-23","kind":"exercise","acquired":false,"shares":10650000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Funds"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On July 23, 2018, the Series A, Series B, Series D, Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A, Series B, Series C, Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 23, 2018, the Series A, Series B, Series D, Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A, Series B, Series C, Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 23, 2018, the Series A, Series B, Series D, Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A, Series B, Series C, Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are directly held by Third Rock Ventures, L.P. (\"TRV\"). The general partner of TRV is Third Rock Ventures GP, L.P. (\"TRV GP\"). The general partner of TRV GP is TRV GP, LLC (\"TRV GP LLC\"). Dr. Tepper is an individual manager of TRV GP LLC. Dr. Tepper disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such shares."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":967389},"source":{"system":"sec-edgar","filing":"0000899243-18-020533","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434418/000089924318020533/doc4.xml","form_type":"4"}},{"id":3862190,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":104809,"kind":"person","name":"Tepper Robert I","position":1,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2018-07-24T19:15:51.000Z","date":"2018-07-23","kind":"exercise","acquired":false,"shares":11000000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Funds"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On July 23, 2018, the Series A, Series B, Series D, Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A, Series B, Series C, Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 23, 2018, the Series A, Series B, Series D, Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A, Series B, Series C, Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 23, 2018, the Series A, Series B, Series D, Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A, Series B, Series C, Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are directly held by Third Rock Ventures, L.P. (\"TRV\"). The general partner of TRV is Third Rock Ventures GP, L.P. (\"TRV GP\"). The general partner of TRV GP is TRV GP, LLC (\"TRV GP LLC\"). Dr. Tepper is an individual manager of TRV GP LLC. Dr. Tepper disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such shares."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":999180},"source":{"system":"sec-edgar","filing":"0000899243-18-020533","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434418/000089924318020533/doc4.xml","form_type":"4"}},{"id":3862189,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":104809,"kind":"person","name":"Tepper Robert I","position":1,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-07-24T19:15:51.000Z","date":"2018-07-23","kind":"purchase","acquired":true,"shares":266667,"price":15,"value":4000005.0,"ownership":{"direct":false,"nature":"By Funds"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are directly held by Third Rock Ventures, L.P. (\"TRV\"). The general partner of TRV is Third Rock Ventures GP, L.P. (\"TRV GP\"). The general partner of TRV GP is TRV GP, LLC (\"TRV GP LLC\"). Dr. Tepper is an individual manager of TRV GP LLC. Dr. Tepper disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such shares."}],"balance_after":2983051,"source":{"system":"sec-edgar","filing":"0000899243-18-020533","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434418/000089924318020533/doc4.xml","form_type":"4"}},{"id":3862188,"issuer":{"id":137050,"kind":"organization","name":"CONSTELLATION PHARMACEUTICALS INC","symbol":"CNST"},"owners":[{"id":104809,"kind":"person","name":"Tepper Robert I","position":1,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-07-24T19:15:51.000Z","date":"2018-07-23","kind":"exercise","acquired":true,"shares":2705334,"ownership":{"direct":false,"nature":"By Funds"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 23, 2018, the Series A, Series B, Series D, Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A, Series B, Series C, Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are directly held by Third Rock Ventures, L.P. (\"TRV\"). The general partner of TRV is Third Rock Ventures GP, L.P. (\"TRV GP\"). The general partner of TRV GP is TRV GP, LLC (\"TRV GP LLC\"). Dr. Tepper is an individual manager of TRV GP LLC. Dr. Tepper disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such shares."}],"balance_after":2716384,"source":{"system":"sec-edgar","filing":"0000899243-18-020533","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434418/000089924318020533/doc4.xml","form_type":"4"}},{"id":3875567,"issuer":{"id":149433,"kind":"organization","name":"Neon Therapeutics, Inc.","symbol":"NTGN"},"owners":[{"id":104809,"kind":"person","name":"Tepper Robert I","position":1,"cik":"0001192595","reported_name":"TEPPER ROBERT I","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2018-07-03T16:29:15.000Z","date":"2018-06-29","kind":"exercise","acquired":false,"shares":0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"All series of Preferred Stock automatically converted into the Issuer's Common Stock on a 5-for-1 basis upon the closing of the Issuer's initial public offering on June 29, 2018 and had no expiration date."},{"field":"shares","element":"transactionShares","label":"F2","text":"TRV III received 341,637 shares of Common Stock of the Issuer upon conversion of 1,708,185 shares of Series B Preferred Stock in connection with the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"All series of Preferred Stock automatically converted into the Issuer's Common Stock on a 5-for-1 basis upon the closing of the Issuer's initial public offering on June 29, 2018 and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All series of Preferred Stock automatically converted into the Issuer's Common Stock on a 5-for-1 basis upon the closing of the Issuer's initial public offering on June 29, 2018 and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"All series of Preferred Stock automatically converted into the Issuer's Common Stock on a 5-for-1 basis upon the closing of the Issuer's initial public offering on June 29, 2018 and had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"TRV III received 341,637 shares of Common Stock of the Issuer upon conversion of 1,708,185 shares of Series B Preferred Stock in connection with the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares are directly held by TRV III. The general partner of TRV III is Third Rock Ventures GP III, L.P. (\"TRV GP III\"). The general partner of TRV GP III is TRV GP III, LLC (\"TRV GP III LLC\"). The individual managers of TRV GP III LLC are Mark Levin (\"Levin\"), Kevin Starr (\"Starr\") and Dr. Robert Tepper (\"Tepper\"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":0},"source":{"system":"sec-edgar","filing":"0001104659-18-043854","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1694187/000110465918043854/a4.xml","form_type":"4"}}],"next_cursor":"2018-07-03T16:29:15.000000Z,3875567"}